Cas No.: | 160588-45-4 |
Chemical Name: | 10,10-Bis((2-fluoropyridin-4-yl)methyl)anthracen-9(10H)-one |
Synonyms: | 10,10-Bis((2-fluoropyridin-4-yl)methyl)anthracen-9(10H)-one;10,10-bis[(2-fluoropyridin-4-yl)methyl]anthracen-9-one;9(10H)-Anthracenone, 10,10-bis[(2-fluoro-4-pyridinyl)methyl]-;DMP 543;HMS3268N10;TCN 237 dihydrochloride;10,10-BIS[(2-FLUORO-4-PYRIDYL)METHYL]ANTHRONE;10,10-BIS[(2-FLUORO-4-PYRIDINYL)METHYL]-9(10H)-ANTHRACENONE;DMP-543 |
SMILES: | FC1C=C(CC2(CC3C=CN=C(F)C=3)C3C(=CC=CC=3)C(=O)C3=C2C=CC=C3)C=CN=1 |
Formula: | C26H18N2OF2 |
M.Wt: | 412.43072 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent blocker of voltage-gated potassium channels Kv7 (KCNQ) that enhances ACh release from rat hippocampal slices in vitro with EC50 of 0.7 uM; maintains the 5- to 10-fold potency differential over linopirdine in increasing extracellular hippocampal ACh levels in the rat with a minimum effective dose of 1 mg/kg.Alzheimer DiseasePhase 2 Discontinued |